[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

US Pharmaceuticals and Biotechnology Industry Comparative Analysis and Companies Ranking

March 2024 | 50 pages | ID: U3CD58DCA4EEN
BAC Reports

US$ 1,000.00

Email Delivery - PDF (on default)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
  • The report analyses Pharmaceuticals and Biotechnology Industry in United States. It covers general statistics, including industry volumes by sales and income, and industry dynamics within the recent period. The description of industry structure by company is included as well, establishing extent of market concentration and evaluating companies’ market shares. Analysis includes detailed information about the internal and external factors that affect Pharmaceuticals and Biotechnology Industry in United States.
  • The report provides detailed Pharmaceuticals and Biotechnology Industry comparative analysis with interrelated data on major companies. The areas under consideration are as follows:
    - company strategic position in the industry
    - profitability and margin analysis
    - assets turnover and credit ratios reviews
    - long-term solvency indicators
    - growth trends comparison
  • The report also presents company rankings by size, value, profit margin and growth history, thus giving a full picture of each company mentioned.
  • The report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases. Annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of the industry.

RESEARCH METHODOLOGY

DISCLAIMER

1. CORPORATE ANALYSIS OF UNITED STATES PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY

1.1. Key Facts
1.2. Industry Volume
1.3. Industry Dynamics

2. UNITED STATES PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY COMPARATIVE ANALYSIS

2.1. Stock Analysis
2.2. Current Market State
2.3. Comparative Financial Analysis
2.3.1. Profitability Analysis
2.3.2. Margin Analysis
2.3.3. Assets Turnover Analysis
2.3.4. Credit Ratios
2.3.5. Long-Term Solvency Analysis
  2.3.6. Growth Over Prior Year Trends

3. UNITED STATES PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY RANKINGS

3.1. Company Rankings by Size
3.2. Company Rankings by Value
3.3. Company Rankings by Profit Margins
3.4. Company Rankings by Growth History

4. UNITED STATES PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY NEWS

4.1. News & PR Activity Analysis
4.2. United States Pharmaceuticals and Biotechnology Industry Significant Developments
4.3. Marketing News
4.4. Corporate Events

5. INDUSTRY EXPERTS FORECAST AND OPINIONS

APPENDIX: RATIO DEFINITIONS


The above Industry Comparative Analysis is a half-ready report.
 It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 3-5 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 40,000 different companies available but it is impossible to have all reports updated immediately. That is why it takes 3-5 days to update a report after an order is received.

LIST OF TABLES 

Table 1. The list of Companies Included in the Research
Table 2. United States Pharmaceuticals and Biotechnology Industry Snapshot
Table 3. United States Pharmaceuticals and Biotechnology Industry Annual Revenues, Gross Profit and Net Income
Table 4. United States Pharmaceuticals and Biotechnology Industry Quarterly Revenues, Gross Profit and Net Income
Table 5. United States Pharmaceuticals and Biotechnology Industry Annual Growth Rates, %
Table 6. United States Pharmaceuticals and Biotechnology Industry Quarterly Growth Rates, %
Table 7. United States Pharmaceuticals and Biotechnology Industry Companies Stock Performance
Table 8. Companies Market Shares, %
Table 9. United States Pharmaceuticals and Biotechnology Industry Companies Profitability Ratios
Table 10. United States Pharmaceuticals and Biotechnology Industry Companies Margin Analysis Ratios
Table 11. United States Pharmaceuticals and Biotechnology Industry Companies Assets Turnover Ratios
Table 12. United States Pharmaceuticals and Biotechnology Industry Companies Credit Ratios
Table 13. United States Pharmaceuticals and Biotechnology Industry Companies Long-Term Solvency Ratios
Table 14. United States Pharmaceuticals and Biotechnology Industry Companies Growth Over Prior Year Ratios
Table 15. United States Pharmaceuticals and Biotechnology Industry Leaders by Market Capitalization
Table 16. United States Pharmaceuticals and Biotechnology Industry Leaders by Revenues
Table 17. United States Pharmaceuticals and Biotechnology Industry Leaders by Net Income
Table 18. United States Pharmaceuticals and Biotechnology Industry Leaders by Employees
Table 19. United States Pharmaceuticals and Biotechnology Industry Leaders by Price per Earnings
Table 20. United States Pharmaceuticals and Biotechnology Industry Leaders by Price to Sales
Table 21. United States Pharmaceuticals and Biotechnology Industry Leaders by Price to Book
Table 22. United States Pharmaceuticals and Biotechnology Industry Leaders by Price to Cash Flow
Table 23. United States Pharmaceuticals and Biotechnology Industry Leaders by Profit Margin
Table 24. United States Pharmaceuticals and Biotechnology Industry Leaders by Operating Margin
Table 25. United States Pharmaceuticals and Biotechnology Industry Leaders by Return on Assets
Table 26. United States Pharmaceuticals and Biotechnology Industry Leaders by Earnings per Share
Table 27. United States Pharmaceuticals and Biotechnology Industry Leaders by Revenue Growth Rate


LIST OF FIGURES

Figure 1. United States Pharmaceuticals and Biotechnology Industry Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Figure 2. Industry Concentration, %
Figure 3. United States Pharmaceuticals and Biotechnology Industry Dynamics, 4 Year Trends
Figure 4. United States Pharmaceuticals and Biotechnology Industry Dynamics, Last 4 Quarter Trends
Figure 5. United States Pharmaceuticals and Biotechnology Industry 1-year Stock Chart
Figure 6. United States Pharmaceuticals and Biotechnology Industry vs. Main Indexes 1-year Stock Chart
Figure 7. United States Pharmaceuticals and Biotechnology Industry Structure by Companies, %
Figure 8. Growth-Share Matrix: Companies Strategic Position in United States Pharmaceuticals and Biotechnology Industry (Recent Year Trends)
Figure 9. Growth-Share Matrix: Companies Strategic Position in United States Pharmaceuticals and Biotechnology Industry (Recent Quarter Trends)
Figure 10. Return on Assets Chart by Companies
Figure 11. Return on Equity Chart by Companies
Figure 12. Profitability Peer Analysis
Figure 13. Profit Margin Chart by Companies
Figure 14. Operating Margin Chart by Companies
Figure 15. Margin Peer Analysis
Figure 16. Assets Turnover Peer Analysis
Figure 17. Current Ratio Chart by Companies in
Figure 18. Growth Over Prior Year Peer Analysis
Figure 19. United States Pharmaceuticals and Biotechnology Industry Article Density Chart


THE FOLLOWING COMPANIES ARE INCLUDED IN THE RESEARCH:

Impact Fusion International Inc.Impax Laboratories Inc.Incyte Corporation
Infinity Pharmaceuticals, Inc.Inhibitex Inc.InNexus Biotechnology, Inc.
Innovative Health Sciences, Inc.Inovio Pharmaceuticals, Inc.Insmed Incorporated
Intellect Neurosciences, Inc.Interleukin Genetics Inc.InterMune Inc.
International Isotopes Inc.International Stem Cell CorporationIntraop Medical Corp.
INVO Bioscience, Inc.IR Biosciences Holdings Inc.Iris Biotechnologies Inc.
Isis Pharmaceuticals, Inc.IsoRay, Inc.ISTA Pharmaceuticals Inc.
Jazz Pharmaceuticals, Inc.Johnson & JohnsonKendle International Inc.
Kent International Holdings Inc.Keryx Biopharmaceuticals Inc.Kiwa Bio-Tech Products Group Corp.
KV Pharmaceutical Co.La Jolla Pharmaceutical Co.Lannett Company, Inc.
Lescarden Inc.Lexicon Pharmaceuticals, Inc.Life Nutrition Products, Inc.
Life Technologies CorporationLifeHealthCare Inc.Lifevantage Corporation
Ligand Pharmaceuticals Inc.LipidViro Tech Inc.Lixte Biotechnology Holdings, Inc.
Apollo Endosurgery, Inc.Luminex CorporationLuna Innovations Incorporated
Manhattan Pharmaceuticals Inc.MannKind Corp.MAP Pharmaceuticals, Inc.
Marina Biotech, Inc.Marshall Edwards Inc.Maxygen, Inc.
Medgenics, Inc.Medicines Co.MediciNova Inc.
Medicis Pharmaceutical Corp.Medivation, Inc.MEDTOX Scientific Inc.
Mera Pharmaceuticals Inc.Merck & Co. Inc.Metabolic Research, Inc.
Metabolix, Inc.MicroHoldings US, Inc.Micromet, Inc.
MiMedx Group, Inc.Momenta Pharmaceuticals Inc.MultiCell Technologies, Inc.
Mylan, Inc.Myrexis, Inc.Myriad Genetics Inc.
Nabi BiopharmaceuticalsNano Dimensions, Inc.Nanosphere, Inc.
NanoViricides, Inc.Naturewell Inc.Nektar Therapeutics
Neogenomics Inc.NeoPharm, Inc.Caladrius Biosciences, Inc.
Neuralstem Inc.Neurobiological Technologies Inc.Neurocrine Biosciences Inc.
NeurogesX, Inc.Neurologix Inc.Nile Therapeutics, Inc
Northwest Biotherapeutics Inc.NovaBay Pharmaceuticals, Inc.Novadel Pharma Inc.
Novavax, Inc.NPS Pharmaceuticals, Inc.NuPathe, Inc.
NuRx Pharmaceuticals, IncNutra Pharma CorporationObagi Medical Products, Inc.
and 359 companies more



More Publications